メタボロミクス(メタボローム解析)の世界市場予測(~2021年):ガスクロマトグラフィー、HPLC、UPLC、NMR、マススペクトロメトリー、表面ベース質量分析、バイオインフォマティクス...市場調査レポートについてご紹介

【英文タイトル】Metabolomics Market by Product (GC, HPLC, UPLC, NMR, Mass Spectrometry, Surface based mass analysis, Bioinformatics), Application (Biomarker & Drug Discovery, Nutrigenomics, Toxicology), Indication (Oncology, Cardiology, Inborn Errors) - Forecast to 2021

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

1 Introduction (Page No. – 25)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology (Page No. – 29)
2.1 Research Approach
2.1.1 Secondary Research
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Research
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.2 Market Size Estimation
2.3 Market Breakdown and Data Triangulation
2.4 Market Share Estimation
2.5 Assumptions for the Study

3 Executive Summary (Page No. – 36)

4 Premium Insights (Page No. – 47)
4.1 Metabolomics Market Overview
4.2 Asia-Pacific: Metabolomics Separation Tools Market, By Type
4.3 Geographic Snapshot: Metabolomics Market
4.4 Geographic Mix: Metabolomics Market
4.5 Metabolomics Market: Developing vs Developed Markets

5 Market Overview (Page No. – 52)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Market Drivers
5.2.1.1 Availability of Government and Private Funding
5.2.1.2 Increasing Pharmaceutical and Biotech R&D Expenditure
5.2.1.3 Technological Advancements
5.2.1.4 Growing Demand for Personalized Medicine
5.2.1.5 Increasing Use of Metabolomics in Toxicology Testing
5.2.2 Key Market Restraints
5.2.2.1 Issues Related to Data Examination and Processing
5.2.2.2 High Cost of Tools and Instruments
5.2.3 Key Market Opportunities
5.2.3.1 Biomarker Development
5.2.3.2 Rapid Growth Opportunities in Emerging Markets
5.2.4 Key Challenges
5.2.4.1 Complexity and Diversity of Biological Samples
5.2.4.2 Dearth of Skilled Researchers

6 Industry Insights (Page No. – 63)
6.1 Introduction
6.2 Industry Trends
6.2.1 Increasing Adoption of Hyphenated Technologies
6.2.2 Tie-Ups Between Instrument Manufacturers and Research Laboratories/Academic Institutions
6.3 Regulatory Analysis

7 Technology Investment Potential (Page No. – 67)
7.1 Introduction
7.2 Investment Client Networks
7.3 Funding Bodies/Initiatives (2012–2016)
7.4 Analysis of Potential Areas for Technology Investment Using Strategic Evaluation
7.4.1 Parameters Considered for Emerging Opportunity Evaluation
7.4.1.1 Level of Attractiveness
7.4.1.2 Probability of Success
7.4.2 Opportunity Strategic Evaluation Analysis
7.4.3 Description of Opportunities
7.4.3.1 Viable (Quadrant 1) – Biomarker Discovery and Lead Optimization in Drug Discovery
7.4.3.1.1 Biomarker Discovery
7.4.3.1.2 Lead Optimization in Drug Discovery
7.4.3.1.3 Toxicity Testing
7.4.3.2 Promising (Quadrant 2) – Companion Diagnostics for Personalized Medicine and Nutrigenomics
7.4.3.2.1 Companion Diagnostics for Personalized Medicine
7.4.3.2.2 Nutrigenomics
7.4.3.2.3 Agriculture
7.4.3.3 Challenging (Quadrant 3) – Environmental Metabolomics
7.4.3.3.1 Environmental Metabolomics
7.4.3.3.2 Functional Genomics

8 Global Metabolomics Market, By Product and Service (Page No. – 74)
8.1 Introduction
8.2 Metabolomics Instruments
8.2.1 Separation Tools
8.2.1.1 High-Performance Liquid Chromatography
8.2.1.2 Gas Chromatography
8.2.1.3 Ultra-Performance Liquid Chromatography
8.2.1.4 Capillary Electrophoresis
8.2.2 Detection Tools
8.2.2.1 Mass Spectrometry
8.2.2.2 Nuclear Magnetic Resonance Spectroscopy
8.2.2.3 Surface-Based Mass Analysis
8.3 Metabolomics Bioinformatics Tools and Services
8.3.1 Bioinformatics Tools & Databases
8.3.2 Bioinformatics Services

9 Global Metabolomics Market, By Application (Page No. – 99)
9.1 Introduction
9.2 Biomarker Discovery
9.3 Drug Discovery
9.4 Toxicology Testing
9.5 Nutrigenomics
9.6 Functional Genomics
9.7 Personalized Medicine
9.8 Other Applications

10 Global Metabolomics Market, By Indication (Page No. – 111)
10.1 Introduction
10.2 Cancer
10.3 Cardiovascular Disorders
10.4 Neurological Disorders
10.5 Inborn Errors of Metabolism
10.6 Other Indications

11 Global Metabolomics Market, By Region (Page No. – 121)
11.1 Introduction
11.2 North America
11.2.1 U.S.
11.2.2 Canada
11.3 Europe
11.3.1 Germany
11.3.2 U.K.
11.3.3 France
11.3.4 Italy
11.3.5 Spain
11.3.6 Rest of Europe
11.4 Asia-Pacific
11.4.1 Japan
11.4.2 China
11.4.3 India
11.4.4 Rest of APAC
11.5 Latin America
11.5.1 Brazil
11.5.2 Mexico
11.5.3 Rest of Latin America
11.6 Middle East and Africa

12 Competitive Landscape (Page No. – 199)
12.1 Overview
12.2 Product Portfolio Analysis
12.3 Market Share Analysis
12.4 Competitive Situations and Trends
12.4.1 Product Launches and Enhancements
12.4.2 Partnerships, Agreements, Collaborations, and Alliances
12.4.3 Expansions
12.4.4 Acquisitions and Divestitures

13 Company Profiles (Page No. – 207)
13.1 Introduction
13.2 Thermo Fisher Scientific Inc.
13.2.1 Business Overview
13.2.2 Products & Services Offered
13.2.3 Recent Developments
13.2.4 MnM View
13.3 Agilent Technologies, Inc.
13.3.1 Business Overview
13.3.2 Products & Services Offered
13.3.3 Recent Developments
13.3.4 MnM View
13.4 Waters Corporation
13.4.1 Business Overview
13.4.2 Products Offered
13.4.3 Recent Developments
13.4.4 MnM View
13.5 Danaher Corporation
13.5.1 Business Overview
13.5.2 Products Offered
13.5.3 Recent Developments
13.5.4 MnM View
13.6 Shimadzu Corporation
13.6.1 Business Overview
13.6.2 Products Offered
13.6.3 Recent Developments
13.6.4 MnM View
13.7 Biocrates Life Sciences AG
13.7.1 Business Overview
13.7.2 Products Offered
13.7.3 Recent Developments
13.8 Bio-Rad Laboratories, Inc.
13.8.1 Business Overview
13.8.2 Products Offered
13.8.3 Recent Developments
13.9 Bruker Corporation
13.9.1 Business Overview
13.9.2 Products & Services Offered
13.9.3 Recent Developments
13.10 Human Metabolome Technologies, Inc.
13.10.1 Business Overview
13.10.2 Products Offered
13.10.3 Recent Developments
13.11 Leco Corporation
13.11.1 Business Overview
13.11.2 Products Offered
13.11.3 Recent Developments
13.12 Metabolon, Inc.
13.12.1 Business Overview
13.12.2 Products Offered
13.12.3 Recent Developments

14 Appendix (Page No. – 259)
14.1 Insights of Industry Experts
14.2 Discussion Guide
14.3 Other Developments
14.4 Knowledge Store: Marketsandmarkets’ Subscription Portal
14.5 Introducing RT: Real-Time Market Intelligence
14.6 Available Customizations
14.7 Related Reports


【レポート販売概要】

■ タイトル:メタボロミクス(メタボローム解析)の世界市場予測(~2021年):ガスクロマトグラフィー、HPLC、UPLC、NMR、マススペクトロメトリー、表面ベース質量分析、バイオインフォマティクス
■ 英文:Metabolomics Market by Product (GC, HPLC, UPLC, NMR, Mass Spectrometry, Surface based mass analysis, Bioinformatics), Application (Biomarker & Drug Discovery, Nutrigenomics, Toxicology), Indication (Oncology, Cardiology, Inborn Errors) - Forecast to 2021
■ 発行日:2017年3月2日
■ 調査会社:MarketsandMarkets
■ 商品コード:MAM-BT-2550
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。